EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The impact of age and renal function on the pharmacokinetics and protein binding characteristics of fludarabine in paediatric and adult patients undergoing allogeneic haematopoietic stem cell transplantation conditioning

Christa E Nath, Sebastian P A Rosser, Kiran K Nath, Jason Chung, Stephen Larsen, John Gibson, Melissa Gabriel, Peter J Shaw, Steven J Keogh

European Journal of Clinical Pharmacology · 2024

DOI: 10.1007/s00228-024-03751-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Pharmacology, 2024. Verfasst von Christa E Nath und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, The Children's Hospital at Westmead, Westmead, NSW, 2145, Australia. christa.nath@health.nsw.gov.au. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Vidarabine, Transplantation Conditioning, Glomerular Filtration Rate. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Institute NSW, University of Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To evaluate the population pharmacokinetics of unbound F-Ara-A (the circulating metabolite of fludarabine) in 211 patients (age range, 0.1–63.4 years) undergoing allogeneic haematopoietic stem cell transplantation conditioning.

Methods

Total ( n = 2480) and unbound ( n = 1403) F-Ara-A concentrations were measured in blood samples collected at timed intervals after fludarabine doses ranging from 10 to 50 mg/m 2 and infused over 0.42–1.5 h. A three-compartment population pharmacokinetic model was developed based on unbound plasma concentrations and used to estimate F-Ara-A unbound pharmacokinetic parameters and fraction unbound ( fu ). A number of covariates, including glomerular filtration rate (GFR) and post-menstrual age (PMA), were evaluated for inclusion in the model.

Results

The base population mean estimates ± relative standard error (%RSE) for unbound clearance from the central compartment (CLu) and inter-compartmental clearances (Q2u, Q3u) were 3.42 ± 3%, 6.54 ± 24% and 1.47 ± 16% L/h/70 kg, respectively. The population mean estimates (%RSE) for the unbound volume of distribution into the central (V1u) and peripheral compartments (V2u, V3u) were 9.65 ± 8%, 8.17 ± 9% and 16.4 ± 10% L/70 kg, respectively, and that for fu was 0.877 ± 1%. Covariate model development involved differentiating F-Ara-A CLu into non-renal (1.81 ± 9% L/h/70 kg) and renal components (1.02 ± 9%*GFR L/h/70 kg). A sigmoidal maturation factor was applied to renal CLu, with population mean estimates for the Hill exponent and PMA at 50% mature of 2.97 ± 4% and 69.1 ± 8% weeks, respectively.

Conclusion

Patient age and GFR are predictors of unbound F-Ara-A CLu. This has the potential to impact dose requirements. Dose individualisation by target concentration intervention will be facilitated by this model once it is externally validated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationVidarabineTransplantation ConditioningGlomerular Filtration RateProtein BindingHumansAdultAdolescentMaleFemaleMiddle AgedChildYoung AdultChild, PreschoolInfantAge FactorsModels, BiologicalTransplantation, HomologousKidney

Stichwörter der Autor:innen

FludarabinePopulation pharmacokineticsProtein binding

Substanzen

Vidarabinefludarabine

Autor:innen und Institutionen

  • Department of Biochemistry, The Children's Hospital at Westmead, Westmead, NSW, 2145, Australia. christa.nath@health.nsw.gov.au.
  • The Cancer Centre for Children, The Children's Hospital at Westmead, Westmead, NSW, 2145, Australia. christa.nath@health.nsw.gov.au.
  • Sydney Pharmacy School, University of Sydney, Camperdown, NSW, 2006, Australia. christa.nath@health.nsw.gov.au.
  • Department of Biochemistry, The Children's Hospital at Westmead, Westmead, NSW, 2145, Australia.
  • The Cancer Centre for Children, The Children's Hospital at Westmead, Westmead, NSW, 2145, Australia.
  • The Children's Hospital at Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia.

Förderung

  • Cancer Institute NSW
  • University of Sydney

Zitieren

APA

Nath, C. E., Rosser, S. P. A., Nath, K. K., Chung, J., Larsen, S., Gibson, J., Gabriel, M., Shaw, P. J., & Keogh, S. J. (2024). The impact of age and renal function on the pharmacokinetics and protein binding characteristics of fludarabine in paediatric and adult patients undergoing allogeneic haematopoietic stem cell transplantation conditioning. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-024-03751-0

Vancouver

Nath CE, Rosser SPA, Nath KK, Chung J, Larsen S, Gibson J, et al. The impact of age and renal function on the pharmacokinetics and protein binding characteristics of fludarabine in paediatric and adult patients undergoing allogeneic haematopoietic stem cell transplantation conditioning. European Journal of Clinical Pharmacology. 2024. doi:10.1007/s00228-024-03751-0

BibTeX
@article{Nath2024,
  author = {Nath, Christa E and Rosser, Sebastian P A and Nath, Kiran K and Chung, Jason and Larsen, Stephen and Gibson, John and Gabriel, Melissa and Shaw, Peter J and Keogh, Steven J},
  title = {The impact of age and renal function on the pharmacokinetics and protein binding characteristics of fludarabine in paediatric and adult patients undergoing allogeneic haematopoietic stem cell transplantation conditioning},
  journal = {European Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1007/s00228-024-03751-0}
}
Kostenlos starten →